SG170065A1 - Human embryonic stem cell methods and podxl expression - Google Patents

Human embryonic stem cell methods and podxl expression

Info

Publication number
SG170065A1
SG170065A1 SG201101522-9A SG2011015229A SG170065A1 SG 170065 A1 SG170065 A1 SG 170065A1 SG 2011015229 A SG2011015229 A SG 2011015229A SG 170065 A1 SG170065 A1 SG 170065A1
Authority
SG
Singapore
Prior art keywords
embryonic stem
human embryonic
cells
stem cell
cell
Prior art date
Application number
SG201101522-9A
Other languages
English (en)
Inventor
Andre Choo
Original Assignee
Agency Science Tech & Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agency Science Tech & Res filed Critical Agency Science Tech & Res
Publication of SG170065A1 publication Critical patent/SG170065A1/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5073—Stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/54—Ovaries; Ova; Ovules; Embryos; Foetal cells; Germ cells
    • A61K35/545—Embryonic stem cells; Pluripotent stem cells; Induced pluripotent stem cells; Uncharacterised stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C12N5/0606—Pluripotent embryonic cells, e.g. embryonic stem cells [ES]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Reproductive Health (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Urology & Nephrology (AREA)
  • Wood Science & Technology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
SG201101522-9A 2006-03-06 2007-03-06 Human embryonic stem cell methods and podxl expression SG170065A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US77891306P 2006-03-06 2006-03-06

Publications (1)

Publication Number Publication Date
SG170065A1 true SG170065A1 (en) 2011-04-29

Family

ID=38475152

Family Applications (1)

Application Number Title Priority Date Filing Date
SG201101522-9A SG170065A1 (en) 2006-03-06 2007-03-06 Human embryonic stem cell methods and podxl expression

Country Status (9)

Country Link
US (2) US8173374B2 (ja)
EP (2) EP1994144B1 (ja)
JP (1) JP5507086B2 (ja)
CN (1) CN101454441B (ja)
AU (1) AU2007222165A1 (ja)
CA (1) CA2644856A1 (ja)
IL (1) IL193883A0 (ja)
SG (1) SG170065A1 (ja)
WO (1) WO2007102787A1 (ja)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8173374B2 (en) 2006-03-06 2012-05-08 Agency For Science, Technology And Research Human embryonic stem cell methods and PODXL expression
WO2009108932A2 (en) * 2008-02-28 2009-09-03 The Johns Hopkins University Selectin ligands useful in the diagnosis and treatment of cancer
SG160248A1 (en) * 2008-09-18 2010-04-29 Agency Science Tech & Res Use of novel monoclonal antibodies targeting human embryonic stem cells to characterize and kill induced pluripotent stem cells
EP2442106B1 (en) * 2009-06-10 2015-08-19 Masanori Hara Method for test on diabetic nephropathy
CN102803472B (zh) * 2009-06-25 2014-04-23 吉隆公司 去除了外来表型的由多能干细胞分化的子代细胞
AU2010269451A1 (en) * 2009-07-08 2012-02-02 Actgen Inc. Antibody having anti-cancer activity
EP2473598B1 (en) 2009-09-04 2017-03-22 The U.S.A. As Represented By The Secretary, Department Of Health And Human Services Methods for enhancing genome stability and telomere elongation in embryonic stem cells
EP2315028A1 (en) 2009-10-26 2011-04-27 Atlas Antibodies AB PODXL protein in colorectal cancer
SG183171A1 (en) 2010-02-04 2012-09-27 Agency Science Tech & Res Use of novel markers of pluripotent stem cells
US8802376B2 (en) 2010-07-21 2014-08-12 Agency For Science, Technology And Research Methods for identifying candidate cytotoxic antibody molecules
US10000739B2 (en) 2010-10-28 2018-06-19 National University Corporation Kumamoto University Method and culture medium for improving pluripotent stem cell differentiation inducing efficiency
JP2014530201A (ja) * 2011-09-20 2014-11-17 イーライ リリー アンド カンパニー 抗ｃ−Ｍｅｔ抗体
EP2746768A1 (en) * 2012-12-20 2014-06-25 Atlas Antibodies AB Podxl in bladder cancer
JP6742581B2 (ja) * 2012-12-21 2020-08-19 学校法人立命館 標的細胞障害活性を有するｉＰＳ／ＥＳ細胞特異的抗体及びその用途
CN103204919B (zh) * 2013-03-29 2014-10-08 浙江大学 胚胎干细胞特异性标志物Aire及其应用
CA2928043A1 (en) * 2013-10-21 2015-04-30 The Centre For Drug Research And Development Anti-podocalyxin antibodies and methods of using the same
US10428312B2 (en) 2013-12-03 2019-10-01 Agency For Science, Technology And Research Cytotoxic antibody
EP3095864B1 (en) 2014-01-14 2020-04-15 Kagoshima University Method for labelling cancerization-causing cell in stem cells
US20170335284A1 (en) * 2014-11-07 2017-11-23 Osaka University Differentiation-induced cell population from which undifferentiated cells have been removed, use of same, and method for producing same
CA3000242A1 (en) * 2015-10-01 2017-04-06 The Centre For Drug Research And Development Anti-podocalyxin antibodies and methods of using the same
EP3604503A4 (en) * 2017-03-28 2020-12-30 Ajinomoto Co., Inc. ADDITIVE FOR DE-DIFFERENTIATION SUPPORT MEDIUM
CN113811601A (zh) * 2018-12-26 2021-12-17 台湾地区“中央研究院” 调节万能性干细胞的潜能的方法及应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4281061A (en) * 1979-07-27 1981-07-28 Syva Company Double antibody for enhanced sensitivity in immunoassay
EP0699237B1 (en) * 1994-03-17 2003-02-19 MERCK PATENT GmbH Anti-egfr single-chain fvs and anti-egfr antibodies
GB9717946D0 (en) * 1997-08-22 1997-10-29 Imp Cancer Res Tech Novel chemical entity
AU2978899A (en) * 1998-03-03 1999-09-20 Abgenix, Inc. Cd147 binding molecules as therapeutics
US7413904B2 (en) * 1998-10-23 2008-08-19 Geron Corporation Human embryonic stem cells having genetic modifications
WO2003046141A2 (en) * 2001-11-26 2003-06-05 Advanced Cell Technology, Inc. Methods for making and using reprogrammed human somatic cell nuclei and autologous and isogenic human stem cells
US20050281828A1 (en) 2003-03-04 2005-12-22 Bowdish Katherine S Method of treating autoimmune disease by inducing antigen presentation by tolerance inducing antigen presenting cells
US20030224411A1 (en) * 2003-03-13 2003-12-04 Stanton Lawrence W. Genes that are up- or down-regulated during differentiation of human embryonic stem cells
CA2568806C (en) * 2003-06-09 2018-07-10 The University Of British Columbia Methods for detecting and treating cancer using podocalyxin and/or endoglycan
US20080026460A1 (en) 2006-06-20 2008-01-31 Palecek Sean P Method for culturing stem cells
US20050233446A1 (en) 2003-12-31 2005-10-20 Parsons Xuejun H Defined media for stem cell culture
US20060182724A1 (en) * 2005-02-15 2006-08-17 Riordan Neil H Method for expansion of stem cells
BRPI0619794B8 (pt) 2005-12-13 2022-06-14 Univ Kyoto Uso de um fator de reprogramação, agente para a preparação de uma célula-tronco pluripotente induzida a partir de uma célula somática e métodos para preparar uma célula- tronco pluripotente induzida método e para preparar uma célula somática e uso de células-tronco pluripotentes induzidas
US8173374B2 (en) * 2006-03-06 2012-05-08 Agency For Science, Technology And Research Human embryonic stem cell methods and PODXL expression
US20060294607A1 (en) 2006-03-29 2006-12-28 Applera Corporation Human podocalyxin alternative-spliced forms and uses thereof
US8968994B2 (en) 2006-07-06 2015-03-03 Jeremy Micah Crook Method for stem cell culture and cells derived therefrom

Also Published As

Publication number Publication date
US8710190B2 (en) 2014-04-29
IL193883A0 (en) 2011-08-01
CN101454441B (zh) 2013-06-26
EP3275901B1 (en) 2020-07-15
EP3275901A1 (en) 2018-01-31
AU2007222165A1 (en) 2007-09-13
US8173374B2 (en) 2012-05-08
JP5507086B2 (ja) 2014-05-28
EP1994144A4 (en) 2009-09-09
JP2009528838A (ja) 2009-08-13
WO2007102787A1 (en) 2007-09-13
EP3275901A8 (en) 2018-03-21
EP1994144A1 (en) 2008-11-26
CN101454441A (zh) 2009-06-10
EP1994144B1 (en) 2017-11-22
US20090214490A1 (en) 2009-08-27
CA2644856A1 (en) 2007-09-13
US20120219962A1 (en) 2012-08-30

Similar Documents

Publication Publication Date Title
SG170065A1 (en) Human embryonic stem cell methods and podxl expression
MX2009006594A (es) Formulaciones de ph regulado y estables que contienen polipeptidos.
MX2008009886A (es) Anticuerpos que enlazan par-2.
WO2006124641A3 (en) Anti-mesothelin antibodies useful for immunological assays
WO2006105152A3 (en) Amnion-derived cell compositions, methods of making and uses thereof
WO2005047524A3 (en) Compositions and methods for inducing cell dedifferentiation
WO2007084321A3 (en) Antibodies to ox-2/cd200 and uses thereof
WO2006076691A8 (en) Irta-2 antibodies and their uses
MX2009013824A (es) Proteinas de enlace de antigeno que enlazan par-2.
EP2534257A4 (en) METHOD OF IDENTIFYING AND ISOLATING CELLS FOR THE EXPRESSION OF POLYPEPTIDES
WO2006089230A3 (en) Human monoclonal antibodies to prostate specific membrane antigen (psma)
MX2010000537A (es) Anticuerpos monoclonales contra glipicano-3.
WO2008118392A3 (en) Synthetic cell platforms and methods of use thereof
MX342595B (es) Anticuerpos anti-il-23 humanos, composiciones, metodos y usos.
WO2006087220A3 (de) Behältnis zur separation von tumorzellen
MX2010008096A (es) Anticuerpos de ferroportina y metodos de uso.
WO2007059190A3 (en) Compositions of and methods of using stabilized psma dimers
WO2007114986A3 (en) Cooperative probes and methods of using them
SI2183599T1 (sl) Visoko občutljiv imunološki preskus in komplet za določanje peptidov in proteinov biološkega interesa
WO2007028079A3 (en) Methods of stimulating expansion of hematopoietic stem cells
CA2735138C (en) Screening methods for transfusion related acute lung injury (trali)
WO2011096894A3 (en) Use of novel markers of pluripotent stem cells
PT2294176T (pt) Adaptador de câmara de amostra, em particular para a criopreservação de amostras biológicas
ATE414277T1 (de) Verfahren zur verhinderung der zeitabhängigen rna-expression in biologischen zellen
WO2009023331A3 (en) Antibodies and improved test sample handling methods for use in assays for myeloperoxidase